Giovanni Caforio, Bristol Myers Squibb CEO (Nicolas Messyasz/Sipa via AP Images)

Scoop: Ab­b­Vie, Bris­tol My­ers bring out the bud­get axe, out­lin­ing plans to lay off more than 350 West Coast em­ploy­ees

WARN no­tices in Cal­i­for­nia have shed light on some of the in­ner work­ings of biotech and phar­ma — and new­ly un­veiled no­tices point at two of the in­dus­try’s largest play­ers.

Ab­b­Vie and Bris­tol My­ers Squibb sep­a­rate­ly no­ti­fied the state ear­li­er this week that they plan on let­ting go 360 em­ploy­ees com­bined by the end of No­vem­ber — al­most 100 at Ab­b­Vie and the rest from Bris­tol My­ers.

Ab­b­Vie did not re­spond to re­peat­ed at­tempts for clar­i­fi­ca­tion from End­points News.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.